Dragon's Den Investing A real-money investing newsletter

Real money. Six stocks. Measured against the S&P 500.

In 2025 the portfolio returned +26.61% against the S&P 500's +16.39%. Every quarter is published — the winning ones and the losing ones — because the only score that matters is portfolio minus index.

Track record

The scorecard, wins and losses.

Ahead in 2025, behind so far in 2026. Both are published here — a track record that hides its down quarters isn't a track record. Q3 to date updates live during market hours.

+26.61%2025 portfolio return
vs S&P 500 +16.39%
−13.3%Q1 2026
vs S&P 500 −5.1%
+10.6%Q2 2026
vs S&P 500 +14.9%
−4.2%2026 year-to-date
vs S&P 500 +9%
Q3 2026 to date · portfolio LIVE
Q3 2026 to date · S&P 500
Portfolio − S&P

Live estimate during market hours (Mon–Fri 6:30 AM–1:00 PM MST) · · estimated portfolio value

Full quarterly history and prediction grades →

How it works

Four pillars, one portfolio.

Technology, geopolitics, and stock picking — acted on with real dollars, not just opinions.

I

Concentrated conviction

About six stocks. "Safe" compounders paired with volatile high-upside names — and the first-to-sell candidates named up front, not after the fact.

II

Distribution & data win

In AI, moated distribution beats foundation models. The real progress shows up in biotech and in platforms that already reach billions.

III

Geopolitics first

Five years living in China taught that tariffs, trade truces, and supply chains move sectors before earnings do. Macro is a lens, not a prediction.

IV

Radical transparency

Quarterly performance with dollar tables and cost bases. Predictions graded A–F. Mistakes published — including the ones that still hurt.

Read the full framework →

Current holdings

Six positions. Nothing hidden.

End-of-2025 weights and cost bases, published with every thesis and what would change it.

TickerCompanyWeightCost basis2025 return
METAMeta Platforms42.42%$93.67+12.74%
HALOHalozyme Therapeutics19.46%$53.26+40.77%
NETCloudflare11.77%$40.08+83.09%
NTRANatera10.94%$147.35+44.72%
UUnity Software7.39%$28.18+96.57%
CELHCelsius Holdings4.34%$46.07+68%

Weights and cost bases as of December 31, 2025. Dollar position sizes are shared with paid subscribers only.

Theses and "what would change my mind" →

From the newsletter

Latest essays.

Theses, macro, and performance narratives — free posts open to everyone, trade alerts reserved for paid subscribers.

Jul 6, 2026 · Free

Q2 Results & Thoughts on Recent Semi Boom

The Q2 rebound, and why the semiconductor boom still doesn't get a dollar from this portfolio.

Read on Substack →
Apr 6, 2026 · Paid

Q1 '26 Reflections and Performance

Down 13.3% in a quarter — "puts me in line with Cathie Wood… that hurts."

Read on Substack →
Mar 30, 2026 · Free

On Sticking With Your Thesis

Judge the thesis, not the price — plus the Drunkenmiller entry-discipline framework.

Read on Substack →
Feb 17, 2026 · Free

Thoughts on Software's Big Selloff

Software fell off a cliff on AI fears. Why META, NET, and Unity are held through the storm.

Read on Substack →

Browse all 15 essays →

Watch six stocks try to beat the index.

Free posts: theses, macro, and performance narratives. Paid: instant buy/sell alerts, portfolio actuals, and the full archive.

$8/month · $80/year · Founding $240